Elmedical

Thermal Treatments for Bladder Cancer and Prostatitis

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in April 2003 by Uzi Eshel and Jacob Lazarovitz, Elmedical operates with 1–10 employees. The company focuses on developing medical devices for urological diseases. In January 2016, a study was published on the efficacy and safety of its device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC.

Business overview

Elmedical develops and provides office-based systems for minimally invasive, non-ablative, high-temperature treatments (hyperthermia) targeting unmet urological diseases such as bladder cancer and prostatitis. Its core technologies include Bladder Wall Thermochemotherapy (BWT), which delivers chemotherapy at a precise temperature for bladder cancer, and DuoThermia, which simultaneously treats the prostate and bladder for chronic prostatitis/chronic pelvic pain syndrome. The company serves the healthcare industry with a focus on medical devices and therapeutic solutions.

Strategic signal

In January 2016, a phase I-II study was published in PubMed, highlighting the efficacy and safety of Elmedical's device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC. This publication provides clinical validation for the company's technology, signaling its potential in advancing treatment options for bladder cancer and offering a data-backed foundation for further clinical adoption and investor interest in its medical device solutions.

Company Intelligence Q&A

What is Elmedical's primary focus?
Elmedical specializes in developing and providing office-based systems for minimally invasive, high-temperature thermal treatments for urological diseases like bladder cancer and prostatitis.
When was Elmedical founded?
Elmedical was founded in April 2003.
Who are the founders of Elmedical?
Elmedical was co-founded by Uzi Eshel and Jacob Lazarovitz.
What is Bladder Wall Thermochemotherapy (BWT)?
Bladder Wall Thermochemotherapy (BWT) is Elmedical's system for chemotherapy instillation at a uniform and precise 44 to 44.5 degrees Celsius over the entire bladder lumen, used for bladder cancer treatment.
What is DuoThermia?
DuoThermia is Elmedical's treatment for chronic prostatitis/chronic pelvic pain syndrome in males, involving simultaneous hyperthermia of the prostate and bladder using a heated balloon and circulating heated saline.